VIR22-9

Sessions and Objectives

Session 1: Introduction to vaccine R&D, manufacturing, and technology transfer to ramp up capacity

Date: 11/02/2022 Duration: 0.25 (h)

Number of participants: Men(0) / Women(0)

Objective: Improve knowledge and understanding of the practical aspects of vaccine R&D, manufacturing, and technology transfer to ramp up capacity.

Category: Improve knowledge of WTO Agreements or particular area of Agreements, of WTO negotiations, of WTO Committees or WTO subjects

Indicators:
  • Indicator: Other

    Evidence: Questions and comments submitted via the Zoom chat showed the keen interest in the session delivered by: Dr Matthew Downham Director, Manufacturing & Supply Chain Networks Coalition for Epidemic Preparedness Innovations

Conclusion: Session 1 was a short, introductory session. Dr Downham is a world-recognized expert on vaccine R&D, manufacturing and technology transfer.

Results: Fully

Session 2: Vaccine inputs' sourcing and global value chains

Date: 11/02/2022 Duration: 0.25 (h)

Number of participants: Men(0) / Women(0)

Objective: Improve knowledge and understanding of the practical aspects of vaccine inputs' sourcing and global value chains.

Category: Improve knowledge of WTO Agreements or particular area of Agreements, of WTO negotiations, of WTO Committees or WTO subjects

Indicators:
  • Indicator: Other

    Evidence: Questions and comments submitted via the Zoom chat showed the keen interest in the session delivered by: Mr Jim Cafone Vice President for Strategy and Operations Management Pfizer.

Conclusion: Session 2 was a short and lively session. Mr Cafone is a senior executive from one of the main vaccine manufacturers, he provided a practical account of the experience sourcing inputs and the establishment of the global value chains for the COVID-19 vaccine.

Results: Fully

Session 3: The regulatory dimension

Date: 11/02/2022 Duration: 0.25 (h)

Number of participants: Men(0) / Women(0)

Objective: Improve knowledge and understanding of the regulatory dimension of COVID-19 vaccines .

Category: Improve knowledge of WTO Agreements or particular area of Agreements, of WTO negotiations, of WTO Committees or WTO subjects

Indicators:
  • Indicator: Other

    Evidence: Questions and comments submitted via the Zoom chat showed the keen interest in the session delivered by Ms Carmen Rodríguez Hernández Team Lead Vaccines Prequalification, Regulation and Prequalification Department Access to Medicines and Health Products WHO Ms Priti Shah Executive Director, International Regulatory Affairs, AstraZeneca Dr Henrietta Ukwu Senior Vice President and Chief Regulatory Officer Novavax

Conclusion: Session 3 exposed participants to the intricacies of the regulatory dimension of COVID-19 vaccines. The three speakers are global experts and shared their experiences in bringing vaccines to patients.

Results: Fully

Session 4: Distributing vaccines globally

Date: 11/02/2022 Duration: 0.30 (h)

Number of participants: Men(0) / Women(0)

Objective: Improve knowledge and understanding of the process for distributing vaccines globally.

Category: Improve knowledge of WTO Agreements or particular area of Agreements, of WTO negotiations, of WTO Committees or WTO subjects

Indicators:
  • Indicator: Other

    Evidence: Questions and comments submitted via the Zoom chat showed the keen interest in the session delivered by Mr Jean-Pierre Amorij Technical Specialist, Vaccine Centre UNICEF Mr Carlos Enríquez Montes Senior Director for Regulatory Affairs DHL Express

Conclusion: Session 4 delivered a real-life account of the global distribution of COVID-19 vaccines, the challenges, lessons learned and the best practices that should be kept for the future.

Results: Fully

Session 5: Getting vaccines into arms

Date: 11/02/2022 Duration: 0.40 (h)

Number of participants: Men(0) / Women(0)

Objective: Improve knowledge and understanding of the actions required to successfully turn vaccines into vaccinations (getting shots into arms).

Category: Improve knowledge of WTO Agreements or particular area of Agreements, of WTO negotiations, of WTO Committees or WTO subjects

Indicators:
  • Indicator: Other

    Evidence: Questions and comments submitted via the Zoom chat showed the keen interest in the session delivered by: Dr Ann Lindstrand Unit Head, EPI-Essential Programme on Immunization, WHO Dr Aakash Mohpal Senior Economist Health, Nutrition and Population Global Practice, World Bank Prof. Bouchra Meddah Director, Medicines and Pharmacy Ministry of Health and Social Protection, Morocco Mr Felipe Muñoz Head of Administration and Logistics, Immunization Programme, Chile Dr Chansay Patthammavong Deputy National Immunization Program Ministry of Health, Lao PDR

Conclusion: Session 5 delivered addressed all the steps, sequence and resources required to get vaccines into arms.

Results: Fully